About this document

SSRIs: Risks vs. Benefits Analysis by zul090 is a document available to read on EtoBox.

This document discusses selective serotonin reuptake inhibitor (SSRI) drugs and their risks and benefits based on various studies and analyses. It notes that at most 30% of patients receive a benefit from SSRIs beyond the large placebo effect, according to a recent meta-analysis. Another meta-analysis found only a small benefit for severely depressed patients. Many early trials did not show any benefit. Adverse effects are common, occurring in up to 75% of subjects, and severe adverse effects may be underre

Author

zul090

Language

EN